Table 1.
Bovine | Human | Porcine | ||||
---|---|---|---|---|---|---|
Serum | FF | Serum | FF | Serum | FF | |
Physiological NEFA | ||||||
Concentrations (μM) | 100–300 | 100–300 | 600–700 | 200 | 200–400; 600–800 | 600–900 |
Composition profile | ||||||
PA | 17% | 22% | – | 23% | 20% | 27% |
SA | 28% | 15% | – | 9% | 17% | 12% |
OA | 22% | 30% | – | 33% | 44% | 33% |
Pathological NEFA | ||||||
Concentrations (μM) | 400–1200 | 200–600 | 700–900 | 300 | 600–1200 | – |
Composition profile | ||||||
PA | 21% | 22% | - | 22% | – | – |
SA | 24% | 13% | - | 13% | – | – |
OA | 35% | 37% | - | 37% | – | – |
References | Leroy et al. (2005) | Leroy et al. (2005) | Igosheva et al. (2010), Valckx et al. (2012, 2014b) | Valckx et al. (2014b) | Yao et al. (1980), Hoving et al. (2012) | Yao et al. (1980) |